159 related articles for article (PubMed ID: 37831114)
1. RGD-decorated nanoliposomes for combined delivery of arsenic trioxide and curcumin to prostate cancer cells.
Khosravani F; Amiri F; Mahmoudi R; Morshedi D; Kobarfard F; Alipour M; Hosseini E; Bardania H
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2347-2357. PubMed ID: 37831114
[TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide and Erlotinib loaded in RGD-modified nanoliposomes for targeted combination delivery to PC3 and PANC-1 cell lines.
Khosravani F; Mir H; Mirzaei A; Kobarfard F; Bardania H; Hosseini E
Biotechnol Appl Biochem; 2023 Apr; 70(2):811-823. PubMed ID: 36070882
[TBL] [Abstract][Full Text] [Related]
3. RGD peptide-mediated liposomal curcumin targeted delivery to breast cancer cells.
Mahmoudi R; Ashraf Mirahmadi-Babaheidri S; Delaviz H; Fouani MH; Alipour M; Jafari Barmak M; Christiansen G; Bardania H
J Biomater Appl; 2021 Feb; 35(7):743-753. PubMed ID: 32807016
[TBL] [Abstract][Full Text] [Related]
4. Intercalation of curcumin into liposomal chemotherapeutic agent augments apoptosis in breast cancer cells.
Mahmoudi R; Hassandokht F; Ardakani MT; Karimi B; Roustazadeh A; Tarvirdipour S; Barmak MJ; Nikseresht M; Baneshi M; Mousavizadeh A; Shirazi MS; Alipour M; Bardania H
J Biomater Appl; 2021 Mar; 35(8):1005-1018. PubMed ID: 33283585
[TBL] [Abstract][Full Text] [Related]
5. Curcumin reduces the expression of survivin, leading to enhancement of arsenic trioxide-induced apoptosis in myelodysplastic syndrome and leukemia stem-like cells.
Zeng Y; Weng G; Fan J; Li Z; Wu J; Li Y; Zheng R; Xia P; Guo K
Oncol Rep; 2016 Sep; 36(3):1233-42. PubMed ID: 27430728
[TBL] [Abstract][Full Text] [Related]
6. Novel and efficient method for loading aptamer-conjugated liposomes with arsenic trioxide for targeting cancer cells.
Mirveis Z; Kouchak M; Mahdavinia M; Rahbar N
J Liposome Res; 2022 Sep; 32(3):276-283. PubMed ID: 34918592
[TBL] [Abstract][Full Text] [Related]
7. Engineered tumor microvesicles modified by SP94 peptide for arsenic trioxide targeting drug delivery in liver cancer therapy.
Raza F; Zheng M; Zhong H; Su J; He B; Yuan WE; Qiu M
Biomater Adv; 2023 Dec; 155():213683. PubMed ID: 37925825
[TBL] [Abstract][Full Text] [Related]
8. AS1411aptamer conjugated liposomes for targeted delivery of arsenic trioxide in mouse xenograft model of melanoma cancer.
Shariat Razavi F; Kouchak M; Sistani Karampour N; Mahdavinia M; Nazari Khorasgani Z; Rezaie A; Rahbar N
J Liposome Res; 2024 Jun; 34(2):288-302. PubMed ID: 37843918
[TBL] [Abstract][Full Text] [Related]
9. RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma.
Fei W; Zhang Y; Han S; Tao J; Zheng H; Wei Y; Zhu J; Li F; Wang X
Int J Pharm; 2017 Mar; 519(1-2):250-262. PubMed ID: 28109899
[TBL] [Abstract][Full Text] [Related]
10. Human prostate cancer cell epithelial-to-mesenchymal transition as a novel target of arsenic trioxide and curcumin therapeutic approach.
Mirzaei A; Jahanshahi F; Khatami F; Reis LO; Aghamir SMK
Tissue Cell; 2022 Jun; 76():101805. PubMed ID: 35487055
[TBL] [Abstract][Full Text] [Related]
11. Co-encapsulation of hydrophilic and hydrophobic drugs into niosomal nanocarrier for enhanced breast cancer therapy: In silico and in vitro studies.
Amiri S; Pashizeh F; Moeinabadi-Bidgoli K; Eyvazi Y; Akbari T; Salehi Moghaddam Z; Eskandarisani M; Farahmand F; Hafezi Y; Nouri Jevinani H; Seif M; Mousavi-Niri N; Chiani M; Tavakkoli Yaraki M
Environ Res; 2023 Dec; 239(Pt 2):117292. PubMed ID: 37806480
[TBL] [Abstract][Full Text] [Related]
12. Targeted Mesoporous Silica Nanoparticles Delivering Arsenic Trioxide with Environment Sensitive Drug Release for Effective Treatment of Triple Negative Breast Cancer.
Wu X; Han Z; Schur RM; Lu ZR
ACS Biomater Sci Eng; 2016 Apr; 2(4):501-507. PubMed ID: 33465854
[TBL] [Abstract][Full Text] [Related]
13. Curcumin antagonizes inflammation and autophagy induced by arsenic trioxide through immune protection in duck spleen.
Tang L; Lan J; Jiang X; Huang R; Pang Q; Wu S; Wan F; Zhong G; Tang Z; Hu L
Environ Sci Pollut Res Int; 2022 Oct; 29(50):75344-75355. PubMed ID: 35653021
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of liposomes encapsulating atorvastatin calcium and curcumin and targeting dysfunctional endothelial cells in reducing atherosclerosis.
Li X; Xiao H; Lin C; Sun W; Wu T; Wang J; Chen B; Chen X; Cheng D
Int J Nanomedicine; 2019; 14():649-665. PubMed ID: 30697048
[TBL] [Abstract][Full Text] [Related]
15. Formulation, development and evaluation of hyaluronic acid-conjugated liposomal nanoparticles loaded with regorafenib and curcumin and their in vitro evaluation on colorectal cancer cell lines.
Shnaikat SG; Shakya AK; Bardaweel SK
Saudi Pharm J; 2024 Jul; 32(7):102099. PubMed ID: 38817822
[TBL] [Abstract][Full Text] [Related]
16. Tuftsin-Bearing Liposomes Co-Encapsulated with Doxorubicin and Curcumin Efficiently Inhibit EAC Tumor Growth in Mice.
Murugesan K; Srinivasan P; Mahadeva R; Gupta CM; Haq W
Int J Nanomedicine; 2020; 15():10547-10559. PubMed ID: 33414637
[TBL] [Abstract][Full Text] [Related]
17. A Novel Delivery System of RGD-HSA Loaded GEM/CUR Nanoparticles for the Treatment of Pancreatic Cancer Therapy.
Ma T; Jiang JL; Qi WX; Chen JY; Xu HP
Drug Des Devel Ther; 2022; 16():2395-2406. PubMed ID: 35923931
[TBL] [Abstract][Full Text] [Related]
18. A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system.
Lu Y; Han S; Zheng H; Ma R; Ping Y; Zou J; Tang H; Zhang Y; Xu X; Li F
Int J Nanomedicine; 2018; 13():5937-5952. PubMed ID: 30323584
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of curcumin on ATO-induced nephrotoxicity in ducks in relation to suppressed autophagy, apoptosis and dyslipidemia by regulating oxidative stress.
Wu S; Yu W; Jiang X; Huang R; Zhang X; Lan J; Zhong G; Wan F; Tang Z; Hu L
Ecotoxicol Environ Saf; 2021 Aug; 219():112350. PubMed ID: 34022626
[TBL] [Abstract][Full Text] [Related]
20. Combined anticancer effects of simvastatin and arsenic trioxide on prostate cancer cell lines via downregulation of the VEGF and OPN isoforms genes.
Mirzaei A; Rashedi S; Akbari MR; Khatami F; Aghamir SMK
J Cell Mol Med; 2022 May; 26(9):2728-2740. PubMed ID: 35366048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
